Israel's Therapix Biosciences to be acquire for $48M

Note: This section contains information in English only.
Source: Dukascopy Bank SA
Canada's FSD Pharma is planning to acquire the Israeli firm Therapix Biosciences in an all=stock deal worth $48M that would combine two complementary units focused on the R&D of cannabinoid treatments.
Back to articles

Actual Topics

Tue, 23 Oct 2018 09:37:23 GMT

Dreyfus' Biosev arm discusses selling more assets

The Brazilian ethanol and sugar producer unit Biosev, owned by Louis Dreyfus, is negotiating a sale of more assets in Brazil, seeking to trim debt.

Tue, 23 Oct 2018 08:28:03 GMT

J&J to acquire Japan's Ci:z in $2.1B deal

Johnson & Johnson, the US healthcare conglomerate, announced on Tuesday it would acquire all the outstanding shares of Japan's cosmetics company Ci:z Holdings in a deal valued at $2.1B.

Subscribe to "Fundamental Analysis" feed

Souscrire
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.
To learn more about Dukascopy Bank Binary Options / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information,
please call us or make callback request.
To learn more about Business Introducer and other trading related information,
please call us or make callback request.
For further information regarding potential cooperation,
please call us or make callback request.